Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NYSE MKT LLC
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

VolitionRX Ltd

+ Add to Watchlist

VNRX:US

3.0000 USD 0.2501 7.70%

As of 20:04:04 ET on 05/06/2015.

Snapshot for VolitionRX Ltd (VNRX)

Open: 3.7500 Day's Range: 2.8100 - 3.7500 Volume: 69,322
Previous Close: 3.2501 52wk Range: 1.3000 - 9.2799 1-Yr Rtn: +42.86%

Stock Chart for VNRX

No chart data available.
  • VNRX:US 3.0000
  • 1D
  • 1M
  • 1Y
3.2501
Interactive VNRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VNRX

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2015) -0.5050
Est. PEG Ratio -
Market Cap (M USD) 53.80
Shares Outstanding (M) 17.93
30 Day Average Volume 27,284
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VNRX

No data available

Company Profile & Key Executives for VNRX

Volition RX Ltd manufactures epigenetic cancer detection blood tests. The Company's tests are designed to detect the nucleosome patterns that are specific to cancer in the blood, and identify some of the major nucleosome varieties that differ between cancer types.

Martin C FaulkesChairmanCameron ReynoldsPresident/CEO
Mike O ConnellCFO/TreasurerJacob MicallefChief Scientific Ofcr
More Company Profile & Key Executives for VNRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil